Skeletal Muscle Purine Nucleotide Degradation and Atrophy: Cause or Consequence of Increased Uric Acid Production

Simple item page
dc.access.optionOpen Access
dc.contributor.advisorCortright, Ronald
dc.contributor.authorMiller, Spencer Graham
dc.contributor.committeeMemberBrault, Jeffrey
dc.contributor.committeeMemberWitczak, Carol
dc.contributor.committeeMemberFisher-Wellman, Kelsey
dc.contributor.committeeMemberMansfield, Kyle
dc.contributor.departmentKinesiology
dc.date.accessioned2023-02-10T18:21:09Z
dc.date.available2024-07-01T08:02:00Z
dc.date.created2022-07
dc.date.issued2022-07-26
dc.date.submittedJuly 2022
dc.date.updated2023-01-31T21:14:28Z
dc.degree.departmentKinesiology
dc.degree.disciplinePHD-Bioenergetics and Exer Sci
dc.degree.grantorEast Carolina University
dc.degree.levelDoctoral
dc.degree.namePh.D.
dc.description.abstractElevated serum uric acid is a risk factor for mortality in diseases and critical illnesses associated with skeletal muscle atrophy. Uric acid is generated by xanthine oxidoreductase (XOR) and XOR inhibitors can partially attenuate muscle atrophy. Whether purine nucleotide degradation in atrophying muscle fibers contributes to increased XOR activity and serum uric acid, and whether uric acid is sufficient to induce muscle atrophy are unknown. Aim 1. To determine if purine nucleotide degradation is increased in atrophying skeletal muscle and its contribution to elevated uric acid production. Muscle atrophy was induced in mice by fasting and dexamethasone (DEX), and C2C12 myotubes by DEX and constitutively active FoXO3 (caFoXO3). Purines (hypoxanthine, xanthine, uric acid) were measured in serum, extensor digitorum longus (EDL) incubation buffer, or culture media by ultra-performance liquid chromatography (UPLC). Fasting and DEX significantly increased serum uric acid and uric acid release from atrophying EDL muscles. In myotubes DEX- and caFoXO3-induced atrophy caused increased hypoxanthine and xanthine (uric acid precursors) efflux, but little to no uric acid due to lack of XOR expression. Co-culturing atrophying myotubes with endothelial cells (which did express XOR), increased media uric acid solely from the oxidation of myotube purines. These findings demonstrate that purine nucleotide degradation coincides with increased protein degradation in atrophying skeletal muscles. Increased purine release from muscle cells can drive XOR activation in XOR-expressing cells and contributes to increased serum uric acid. Aim 2. To determine if uric acid can directly increase muscle protein degradation and cause muscle atrophy. C2C12 myotubes were treated with physiological levels (175, 350, or 700 µM) of uric acid for 48 hours. Myotube proteins were labeled with 13C15N-Phe and changes in 13C15N-Phe were quantified by UPLC and used to calculate protein degradation rates. Media and intracellular uric acid were determined by UPLC. Uric acid exposure did not increase protein degradation rates or reduce total protein in culture wells. Media uric acid was not reduced after 48 h but intracellular uric acid was significantly increased in myotubes. These findings demonstrated that while uric acid can accumulate in muscle cells, it does not directly increase muscle protein degradation or cause atrophy.
dc.embargo.lift2024-07-01
dc.format.mimetypeapplication/pdf
dc.identifier.urihttp://hdl.handle.net/10342/12238
dc.language.isoen
dc.publisherEast Carolina University
dc.subjectMuscle atrophy
dc.subjecturic acid
dc.subjectxanthine oxidase
dc.subjectAMP deaminase
dc.titleSkeletal Muscle Purine Nucleotide Degradation and Atrophy: Cause or Consequence of Increased Uric Acid Production
dc.typeDoctoral Dissertation
dc.type.materialtext

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
MILLER-DOCTORALDISSERTATION-2022.pdf
Size:
3.56 MB
Format:
Adobe Portable Document Format
Download

Collections

Dissertations
Kinesiology